Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Participate in September Investor Conferences
CAMBRIDGE, Mass., August 31, 2021—Korro Bio, Inc., an RNA editing company focused on the discovery and development of novel genetic medicines, today announced that Ram Aiyar, Ph.D., MBA, chief executive officer, will present at the 2021 Wells Fargo Healthcare Conference and participate in a fireside chat at the 2021 Morgan Stanley Global Healthcare Conference.
Dr. Aiyar will be presenting at the Wells Fargo Healthcare Conference on September 10, 2021 at 12:40 p.m. The event will be livestreamed on the conference website.
The fireside chat at the Morgan Stanley Global Healthcare conference will be held on September 14, 2021 at 2:45 p.m.
About Korro Bio, Inc.
Korro is an RNA editing company focused on discovery and development of a new class of precision genetic medicines. The synthetic oligonucleotide platform, OPERATM, is a modular drug discovery engine that combines proprietary data-driven design with off-the-shelf chemistry and delivery to achieve highly selective RNA editing. This unique technology enables the functional benefits of gene therapy with a transient, repeated-administration regimen that permits pharmacologic titration of therapeutic efficacy and safety. As a result, Korro’s portfolio of innovative RNA therapies have the potential to propel genetic medicine beyond rare genetic diseases into larger patient populations with common diseases. Korro is located in Cambridge, Mass. For more information, visit korrobio.com.
Ten Bridge Communications